Correction: A Dominant-Negative FGF1 Mutant (the R50E Mutant) Suppresses Tumorigenesis and Angiogenesis

Podobne zapisy

• A Dominant-Negative FGF1 Mutant (the R50E Mutant) Suppresses Tumorigenesis and Angiogenesis
  od: Mori, Seiji, i wsp.
  Wydane: (2013)
• The integrin-binding defective FGF2 mutants potently suppress FGF2 signalling and angiogenesis
  od: Mori, Seiji, i wsp.
  Wydane: (2017)
• An Integrin Binding-defective Mutant of Insulin-like Growth Factor-1 (R36E/R37E IGF1) Acts as a Dominant-negative Antagonist of the IGF1 Receptor (IGF1R) and Suppresses Tumorigenesis but Still Binds to IGF1R
  od: Fujita, Masaaki, i wsp.
  Wydane: (2013)
• Mammary Tumorigenesis following Transgenic Expression of a Dominant Negative CHK2 Mutant
  od: Kwak, Eunice L., i wsp.
  Wydane: (2006)
• Random Screening for Dominant-Negative Mutants of the Cytomegalovirus Nuclear Egress Protein M50
  od: Rupp, Brigitte, i wsp.
  Wydane: (2007)